Staff at Salt Lake City-based techbio company Recursion recently heard from Jenny and Tim Jones about their challenging family history of familial adenomatous polyposis. Most of the Recursion staff ...

Researchers found that the body’s natural recycling system, the lysosome, plays a vital role in removing the protein that drives premature aging. When this system breaks down, aging speeds up. By ...

Scientists have discovered that combining two existing drugs can dramatically reduce liver fat linked to a common and often silent disease. The treatment not only improved liver health in animal ...

AMC Theatres is again raising the price of Stubs A-List, citing the rising costs of operating its venues. Starting July 15, the cinema chain’s movie subscription membership will cost $29.99 per month, ...

A new report dubbed "BrowserGate" warns that Microsoft's LinkedIn is using hidden JavaScript scripts on its website to scan visitors' browsers for installed extensions and collect device data.

WASHINGTON, March 27 (Reuters) - Iran-linked hackers have broken into FBI Director Kash Patel's personal email inbox, publishing photographs of the director and other documents to the internet, the ...

How much would you pay to get a new job? Ask around, and job seekers will tell you it's harder to land an interview or offer today than it has been in years. It's not uncommon to hear from people who ...

Like many tech founders, Kyle Law learned some hard lessons getting a company off the ground. I know this better than anyone, as he and I cofounded HurumoAI, an AI agent startup, together with a third ...

So, you’re looking to get better at LeetCode, huh? It can feel like a huge mountain to climb with all those problems. But honestly, it’s not just about grinding through endless coding challenges.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer answered questions about. When a caller mentioned that Cathie Wood invested in the stock, Cramer remarked, “That’s, it’s a ...

Compounds found in cannabis could provide a new roadmap for treating the world’s most common chronic liver disorder, according to a study released by the Hebrew University of Jerusalem. The research, ...